TerrAscend (TSNDF) Other Non Operating Income (2021 - 2026)

TerrAscend's (TSNDF) quarterly Other Non Operating Income came in at $428000.0 in Q1 2026, up 1119.05% year-on-year from $35109.4 in Q1 2025, and down 81.55% on a QoQ basis from $2.3 million in Q4 2025.

TerrAscend (TSNDF) Other Non Operating Income (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 6 years of Other Non Operating Income data on file, last reported at $428000.0 in Q1 2026.

  • On a quarterly basis, Other Non Operating Income rose 1119.05% year-over-year to $428000.0 in Q1 2026; TTM through Mar 2026 was $3.7 million, a 80.03% increase from a year earlier, with the FY2025 full-year figure at $888000.0, down 81.69% from the prior year.
  • Other Non Operating Income for Q1 2026 stood at $428000.0, down from $2.3 million in the prior quarter.
  • Over the last five years, Other Non Operating Income for TSNDF reached as high as $4.3 million in Q4 2024 and fell as low as -$2.1 million in Q3 2024.
  • Historically, Other Non Operating Income has averaged $172705.9 across 5 years, with a median of -$42000.0 in 2025.
  • Across the five-year window, Other Non Operating Income slumped 3786.67% in 2022 and jumped 2551.43% in 2024, its largest moves.
  • Year by year, Other Non Operating Income stood at -$881000.0 in 2022, then soared by 80.14% to -$175000.0 in 2023, then soared by 2551.43% to $4.3 million in 2024, then tumbled by 45.92% to $2.3 million in 2025, then slumped by 81.55% to $428000.0 in 2026.
  • Per Business Quant data, the three most recent Other Non Operating Income figures were $428000.0 in Q1 2026, $2.3 million in Q4 2025, and $291000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 TerrAscend 160.44 Mn 162.98 Mn 34.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 428,000.00
Dec 31, 2025 2.32 Mn
Sep 30, 2025 291,000.00
Jun 30, 2025 648,000.00
Mar 31, 2025 -42,000.00
Dec 31, 2024 4.29 Mn
Sep 30, 2024 -2.10 Mn
Jun 30, 2024 -104,000.00
Mar 31, 2024 -285,000.00
Dec 31, 2023 -175,000.00
Sep 30, 2023 -120,000.00
Jun 30, 2023 101,000.00
Mar 31, 2023 23,000.00
Dec 31, 2022 -881,000.00
Sep 30, 2022 -583,000.00
Jun 30, 2022 -1.15 Mn
Mar 31, 2022 271,000.00
Dec 31, 2021 4.81 Mn
Sep 30, 2021 -15,000.00
Jun 30, 2021 947,000.00